AbbVie
Amgen
Alnylam Pharmaceuticals
Arrowhead Pharmaceuticals
BioGen
Bristol Myers Squibb
Clene Nanomedicine
Horizon Therapeutics
Merck
Nanobiotix
Nanospectra Biosciences
Novartis
Pfizer
Tandem Nano
Published | Pages | Publisher | Report code |
---|---|---|---|
Mar 2022 | 933 | Kuick Research | ASDR-598215 |
AbbVie
Amgen
Alnylam Pharmaceuticals
Arrowhead Pharmaceuticals
BioGen
Bristol Myers Squibb
Clene Nanomedicine
Horizon Therapeutics
Merck
Nanobiotix
Nanospectra Biosciences
Novartis
Pfizer
Tandem Nano